Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 12870783)

Published in Dig Dis Sci on July 01, 2003

Authors

Chin Hur1, Norman S Nishioka, G Scott Gazelle

Author Affiliations

1: Gastrointestinal Unit and Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

Articles cited by this

Hospital volume and surgical mortality in the United States. N Engl J Med (2002) 25.79

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30

Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA (1996) 14.23

Impact of hospital volume on operative mortality for major cancer surgery. JAMA (1998) 11.05

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Markov models in medical decision making: a practical guide. Med Decis Making (1994) 8.14

Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology (2001) 5.80

Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol (1998) 4.68

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making (1993) 4.46

Barrett's esophagus. N Engl J Med (1986) 3.62

The Markov process in medical prognosis. Med Decis Making (1983) 3.58

Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc (1999) 2.65

Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA (1976) 2.55

Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol (1999) 2.50

Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg (1982) 2.26

Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25

Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol (1993) 1.95

Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology. Gastroenterology (1997) 1.92

Combined antegrade and retrograde dilation: a new endoscopic technique in the management of complex esophageal obstruction. Gastrointest Endosc (2001) 1.91

Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (1999) 1.90

Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med (2002) 1.82

Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making (2002) 1.78

Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg (1996) 1.61

A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol (1994) 1.59

Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol (2000) 1.56

Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg (1992) 1.54

The effectiveness of cost-effectiveness analysis in containing costs. J Gen Intern Med (1998) 1.45

The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg (1996) 1.39

Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer (1995) 1.19

Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg (1991) 1.13

Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol (2000) 1.11

Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg (1997) 1.08

Cost-effectiveness of screening the average-risk population for colorectal cancer. Gastrointest Endosc Clin N Am (2002) 0.99

Carcinoma of the esophagus: results of treatment. Ann Surg (1979) 0.83

Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc (1999) 0.79

Articles by these authors

Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology (2003) 5.42

Comprehensive volumetric optical microscopy in vivo. Nat Med (2006) 5.19

Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med (2012) 4.72

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA (2004) 4.36

Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2006) 3.28

American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16

Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc (2008) 2.94

Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88

Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83

Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol (2008) 2.74

Paraesophageal hernias: operation or observation? Ann Surg (2002) 2.71

Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst (2004) 2.53

Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37

Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure. Nat Med (2013) 2.32

Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc (2006) 2.31

Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst (2012) 2.30

Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (2010) 2.28

Comprehensive esophageal microscopy by using optical frequency-domain imaging (with video). Gastrointest Endosc (2007) 2.26

Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg (2006) 2.25

Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer (2003) 2.22

Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc (2010) 1.79

Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc (2009) 1.79

The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology (2012) 1.65

Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol (2008) 1.57

Abdominopelvic CT increases diagnostic certainty and guides management decisions: a prospective investigation of 584 patients in a large academic medical center. AJR Am J Roentgenol (2011) 1.56

Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med (2012) 1.52

Reorganizing the system of care surrounding laparoscopic surgery: a cost-effectiveness analysis using discrete-event simulation. Med Decis Making (2004) 1.51

Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics (2009) 1.48

Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett's esophagus. Dig Dis Sci (2014) 1.44

Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol (2008) 1.42

Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain. AJR Am J Roentgenol (2008) 1.37

A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail (2006) 1.36

Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. J Am Coll Cardiol (2009) 1.34

Calibration of disease simulation model using an engineering approach. Value Health (2009) 1.27

A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res (2008) 1.27

Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer (2008) 1.26

Cost-effectiveness of whole-body CT screening. Radiology (2005) 1.25

XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis (2007) 1.25

Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations. Value Health (2008) 1.24

Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health (2011) 1.22

Temporally and spectrally resolved fluorescence spectroscopy for the detection of high grade dysplasia in Barrett's esophagus. Lasers Surg Med (2003) 1.21

Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg Pathol (2006) 1.20

Comprehensive imaging of gastroesophageal biopsy samples by spectrally encoded confocal microscopy. Gastrointest Endosc (2009) 1.15

Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med (2005) 1.15

Optical coherence tomography of the biliary tree during ERCP. Gastrointest Endosc (2002) 1.14

Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology (2002) 1.14

Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. Med Decis Making (2006) 1.14

Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer (2014) 1.13

Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis. Radiology (2008) 1.13

Diagnostic imaging costs: are they driving up the costs of hospital care? Radiology (2005) 1.11

Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology (2002) 1.11

Long-term acceptance of renal allografts following prenatal inoculation with adult bone marrow. Transplantation (2005) 1.11

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology (2010) 1.09

Multiple-fiber probe design for fluorescence spectroscopy in tissue. Appl Opt (2002) 1.09

Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy. Am J Surg Pathol (2007) 1.09

Use of modeling to evaluate the cost-effectiveness of cancer screening programs. J Clin Oncol (2007) 1.09

Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology (2010) 1.07

Patient predictors of esophageal stricture development after photodynamic therapy. Clin Gastroenterol Hepatol (2008) 1.07

Optoacoustic tomography using time-resolved interferometric detection of surface displacement. J Biomed Opt (2003) 1.05

Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal (2012) 1.05

Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology (2008) 1.04

Elective endovascular versus open surgical repair of abdominal aortic aneurysms: systematic review of short-term results. Radiology (2002) 1.03

Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model. J Vasc Interv Radiol (2004) 1.03

Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol (2005) 1.02

Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis (2008) 1.01

The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol (2007) 0.99

Abdominal and pelvic computed tomography (CT) interpretation: discrepancy rates among experienced radiologists. Eur Radiol (2010) 0.98

Reflectance confocal microscopy for the diagnosis of eosinophilic esophagitis: a pilot study conducted on biopsy specimens. Gastrointest Endosc (2011) 0.98

Falling prey to the sunk cost bias: a potential harm of patient radiation dose histories. Radiology (2012) 0.97

An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand. Gastroenterology (2004) 0.96

Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist (2011) 0.95

Improved coagulation with saline solution pretreatment during radiofrequency tumor ablation in a canine model. J Vasc Interv Radiol (2002) 0.95

Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer (2011) 0.94

Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations. Radiology (2003) 0.94

Cost-effectiveness of PET in the diagnosis of Alzheimer disease. Radiology (2003) 0.93

Adoption and spread of new imaging technology: a case study. Health Aff (Millwood) (2009) 0.93

Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs. Ann Pharmacother (2006) 0.93

Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Gastrointest Endosc (2002) 0.92

Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma. J Clin Oncol (2010) 0.92

Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology (2004) 0.92

Appropriateness and utilization of cardiac CT: implications for development of future criteria. J Nucl Cardiol (2010) 0.91

The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev (2011) 0.91

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers. Cancer (2012) 0.90

Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc (2008) 0.89

CT screening: a trade-off of risks, benefits, and costs. J Clin Invest (2003) 0.89

Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci (2009) 0.87

Biomedical Imaging Research Opportunities Workshop: report and recommendations. Radiology (2003) 0.87

Endoscopic confocal microscopy. Curr Opin Gastroenterol (2005) 0.87

The use of optical coherence tomography in screening and surveillance of Barrett's esophagus. Clin Gastroenterol Hepatol (2005) 0.87

Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One (2010) 0.87

Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol (2004) 0.87

Radiologist report turnaround time: impact of pay-for-performance measures. AJR Am J Roentgenol (2010) 0.86

Medicare's national coverage decisions, 1999-2003: quality of evidence and review times. Health Aff (Millwood) (2005) 0.86

Comparative effectiveness research: what it means for radiology. Radiology (2009) 0.86

The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals. Cancer (2004) 0.86

Patient preferences for the management of high-grade dysplasia in Barrett's esophagus. Dig Dis Sci (2005) 0.85

Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradox. Radiology (2012) 0.85